05-06-2026 16:44 via drugs.com

ASCO: Tile-Based Radiation Beneficial for Newly Resectable Brain Mets

FRIDAY, June 5, 2026-- For patients with newly diagnosed resectable brain metastases (BM), cesium-131 tile-based radiation therapy (TBRT), which delivers focal radiation immediately upon resection, yields significantly better outcomes than...
Read more »

Pharmaceutical Industry news



Prayer at Primary Care Appointments Tied to Reductions in Pain, Anxiety
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2
ASCO: Apalutamide + ADT Beneficial in High-Risk Localized Prostate Cancer
Wearable Ultrasound Patch Provides Continuous Fetal Monitoring
Cardiometabolic Genetics Linked to Cognitive-Related Outcomes
Dose Reduction of Biologics Effective, Safe for Psoriasis
High Prevalence of Clinical Obesity Seen Even With Normal BMI
FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection
ASCO: Lower Incidence of Breast Cancer Seen With GLP-1 Receptor Agonist Exposure
ASCO: First-Line Sunvozertinib Beats Chemo for Advanced NSCLC
Patients From Most Rural Counties Have Worse Epilepsy Outcomes
2024 Saw Parkinson Disease Death Rate of 72 Per 100,000 Adults Aged 65 and Older
Resistance Training Tied to Lower Risk for Death Across Causes
Gut Microbial, Metabolomic Alterations Persist After Adenoma Resection
Desktop versie